Industry

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Regulatory Affairs in China Training Course” conference has been added to ResearchAndMarkets.com’s offering. This seminar will provide an invaluable overview of how to gain and maintain a successful pharmaceutical marketing authorisation in the People’s Republic of China (PRC), including Hong Kong, Macau and Taiwan. The two-day course offers a comprehensive overview of … [Read more…]

CEO to detail THIO-101 expansion trial and upcoming trials in multiple indications CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that Chief Executive Officer Vlad Vitoc, M.D. will present at the Biotech Showcase™ 2025 investor conference taking place in San Francisco, California … [Read more…]

Clinically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1 inhibitor If approved, sasanlimab would be the first PD-1 inhibitor, in combination with BCG, to significantly prolong event-free survival in this patient population Treatment naïve high-risk NMIBC is an area of significant unmet need, where therapeutic … [Read more…]

QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability for up to five targets   No instrument hardware changes required for upgraded capability thanks to new QIAcuity Software 3.1 update and launch of QIAcuity High Multiplex Probe PCR … [Read more…]

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announced that the company has concluded an investment agreement with MPM BioImpact LLC, a Boston-based biotech investment firm (hereafter “MPM BioImpact”). Meiji has committed to invest USD 20 million in MPM BioImpact’s new technologies and virology strategy as a … [Read more…]

SHANGHAI & SUZHOU, China & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a new strategic collaboration and worldwide license agreement with MediLink Therapeutics (Suzhou) Co., Ltd. (“MediLink”) to use MediLink’s TMALIN® antibody-drug conjugate (ADC) platform for the development of a novel LRRC15 ADC, ZL-6201, consisting of an antibody discovered by Zai … [Read more…]

Lipid-Rich Cartilage Tissue has the Potential to Revolutionize Reconstructive Surgery and Regenerative Medicine BPGbio’s Advanced Lipid Analysis Critical to Redefining the Role of Skeletal Tissues   BOSTON–(BUSINESS WIRE)–#bpgbio–BPGbio, a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, is thrilled to announce its contribution to a groundbreaking study published in the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Connected Drug Delivery Devices – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Connected Drug Delivery Devices was estimated at US$5.8 Billion in 2023 and is projected to reach US$22.9 Billion by 2030, growing at a CAGR of 21.7% from 2023 to 2030. This comprehensive report provides … [Read more…]

Visit Pregúntale a Lisa for Free Medical Support Service for California wildfires. BROOKLYN, N.Y.–(BUSINESS WIRE)–HITN is stepping up to assist those affected by the devastating wildfires in Los Angeles County by providing ‘Pregúntale a Lisa’, its free medical support service powered by Vida y Salud. ‘Pregúntale a Lisa’ is a platform that offers a free … [Read more…]

Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatment LYT-200 is currently being evaluated in two Phase 1/2 trials for the potential treatment of AML/MDS and head and neck cancers BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: … [Read more…]